Based out of Oakville, Virox Technologies Inc. is a technology driven company with a strong focus on building a world class organization that is superior at developing and marketing patented Accelerated Hydrogen Peroxide based disinfectants and cleaners that have remarkable and sustainable consumer benefits in every market, around the globe, where disinfectants and cleaners are used.
Virox Technologies is a finalist for the Ontario Global Innovator Award, which will be presented at the Ontario Business Achievement Awards (OBAAs) on November 20th in Toronto. Sponsored by the Government of Ontario, this award goes to an Ontario business whose product has resulted in expanded exports and new jobs.
Virox was incorporated in 1998 when CEO Randy Pilon gathered a group of seed investors to purchase the rights of a novel peroxide disinfectant technology from the inventor. Immediately, Virox sought to secure the intellectual property of the product as it contemplated a series of strategic alliances with industry leaders. Virox wanted to bring this new disinfectant technology to the world and these relationships would facilitate the vision.
With a strong business plan and the ability to put together a talented group of individuals, Virox has successfully gained momentum since the introduction of Accelerated Hydrogen Peroxide (AHPTM) disinfectants in March 1999. Since then, the company has grown exponentially and now has its AHP technology in over 60 countries with seven issued global patents and as many pending with 9 tier-one global alliance partners.
The Ontario Chamber of Commerce is proud to recognize Virox’s contributions to Ontario. Book your table today and find out whether it will shine in the 2013 OBAA spotlight.
Learn more about Virox Technologies in our Q & A.
Tell us about why Virox deserves to win an OBAA?
Innovation in Canada. Infection prevention is in the news. Virox, through its AHP technology is helping save lives in a meaningful way by helping interrupt the spread of infectious disease with hydrogen peroxide, a safer alternative to toxic legacy chemistry.
In 2004 Virox AHP was at the forefront of the SARS outbreak–fighting the spread–and has since garnered a reputation as a next generation solution to this ever evolving issue. Virox’s impressive list of global partners who have licensed our patents demonstrates its international leadership.
What advice do you have for businesses that want to succeed in Ontario?
Essentially, I would suggest that you must have a sustainable competitive advantage to leverage a differentiated strategy. It is a difficult climate to be focused on price so one has to be able to create meaningful profits through sustainable demand for its product or service.
In your experience, what are the key success factors for organizations in your industry?
The business model we built is definitely the key to our success. Open Innovation, a collaborative model before it was in fashion, allowed us to focus on building out the intellectual property portfolio with skilled partners and having a ready and able channel to market once products were ready. Skilled and motivated people, meaningful technology that actually solves a serious problem, combined with strategic execution culminate into an unbeatable force.
How does the Virox improve the everyday lives of Ontarians?
Our corporate mission statement says it all: “Engineering Revolutionary Disinfectants for the War Against Microbes.”